明泰醫療有限公司
請輸入包含最少兩個字母或數字的關鍵字。
FeNO Device TM2120
美元 $4600.00 - 美元 $4800.00
適用年齡:
12-18個月, 嬰幼兒, 長者, 兒童, 成人, 0-3個月, 18-24個月, 9-12個月, 6-9個月, 3-6個月, 幼童, 大童
品牌:
SUNVOU
認證:
ISO 13485, US Patent, CE IVD
顏色:
White
性别:
男女通用
型號編號:
TM2120
電源類型:
乾充兩用
尺寸:
195*145*80mm
重量:
1.0kg
描述
證書及文件
聯絡供應商
描述
FeNO 1+2 is a system that detects, quantifies, and monitors airway inflammation. It's response to pharmacological treatment, therapy, screening, and assessment of Primary Ciliary Dyskinesias (PCD) and accurate measurements of Exhaled Nitric Oxide (NO), bronchial, nasal, and alveolar for early detection and patient management of asthma and inflammation.
- Meets all ERS/ATS /CE-IVD guidelines, standardized tests
- Easy software-driven testing procedure
- Simple, fast, non-invasive measurement with quality control
- Lowest cost per test
- User-accessible NO sensor, long-lasting, typically 24 months or longer.
- Can connect to HIS system
3 TESTING MODES:
- Bronchial - FeNO 50 at a flow rate of 50ml/s with incentive screen.
- Alveolar - FeNO 200/CaNO with automatic Calv and Jaw graphic generation, at different flow rates of 200ml/s
- Nasal - FnNO 5 at a sample flow rate of 10ml/s through a nasal catheter, breathing through resistance for velum closing.
with features Online, Offline, and Tidal modes, allowing for flexible monitoring and assessment of adult, child , and baby
The device can do a "Joint examination of large and small airways and upper and lower airways" 1+2 in one device, and monitor various respiratory diseases, including but not only:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Chronic Cough
- Allergic Rhinitis
- Primary Ciliary Dyskinesia (PCD)
證書及文件
證書名稱
發行機構
證書類型
有效日期
US Patent
發行機構
United States Patent
證書類型
Patent
有效日期
2018年05月15日
-
(不適用)
CE IVD
發行機構
JOYSUN GROUP
證書類型
Others
有效日期
2024年08月13日
-
2025年08月12日
您或許喜歡
確定要取消關注此供應商？